Ventas Inc. stock holds near upper 52-week range after Jefferies Buy rating
Published on 09/16/2026 at 13:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ventas Inc. stock (ISIN US92276F1003) ended the last completed trading session at USD 89.10 on the New York Stock Exchange on September 14, 2026, down 0.99% from the prior close of USD 89.99 based on NYSE data compiled by Yahoo Finance. According to the same overview dated September 14, 2026, the shares traded within a 52-week range between USD 66.54 and USD 101.60, leaving the closing price about USD 12.50 below the 52-week high in a still elevated corridor for the healthcare real estate investment trust.
Jefferies Buy rating and valuation context
Analyst interest in Ventas Inc. provides an important backdrop for investors looking at the current price level. According to GuruFocus on October 3, 2023, Jefferies assumed coverage of Ventas with a Buy rating and set a price target of USD 102.00 for the stock. On that basis, the latest closing price of USD 89.10 on September 14, 2026, stands USD 12.90 below the Jefferies target, indicating further upside potential in the medium term if the company delivers on its strategy.
The same analyst-focused overview indicates that Ventas VTR had a GF Value of USD 73.98 at the time of the report, while the stock traded at USD 88.68 then, implying the shares were viewed as approximately 19.9% overvalued relative to that intrinsic value estimate. According to GuruFocus in that same analysis, Ventas carried a GF Score of 81 out of 100 and a price to earnings ratio on a trailing basis of 164.22, compared with a five year median P/E of 170.68, underscoring that the stock has historically traded at high multiples due to its portfolio quality and growth profile.
Healthcare real estate position and market profile
Beyond the rating, Ventas Inc. draws attention through its scale and specialization within healthcare real estate. According to GuruFocus, Ventas operates in the real estate sector as a REIT and owns a diversified healthcare portfolio of nearly 1,400 properties, including senior housing, medical office buildings and hospitals. The same overview cites an estimated market capitalization of around USD 45.49 billion for Ventas at the time of publication, highlighting its role as one of the larger listed healthcare landlords in the North American market.
For investors, that breadth matters because the company benefits from demographic trends such as aging populations and increasing demand for healthcare services. A portfolio spanning senior living communities and outpatient care facilities can help balance exposure between needs-based long term care and more cyclical medical office demand. At the same time, the high valuation metrics described in the analyst report point to a key risk factor: the shares historically trade at elevated multiples, which may limit future rerating potential if growth or cash flow falls short of expectations.
Stock level relative to 52-week range
From a chart perspective, the latest quote keeps Ventas Inc. stock relatively close to its recent highs without revisiting peak levels. Per NYSE data summarized by Yahoo Finance on September 14, 2026, the 52-week low of USD 66.54 sits about USD 22.56 below the latest close of USD 89.10, while the 52-week high of USD 101.60 stands USD 12.50 above that close. This means the stock is trading materially closer to the top of its yearly range than to the bottom, even after the 0.99% dip compared with the prior session, suggesting that sentiment toward the healthcare REIT remains constructive.
For investors, the quantified relationship between price and range can help frame risk and reward. With the stock roughly one fifth above its 52-week low and somewhat more than one tenth below its high, recent trading leaves room for both potential gains and pullbacks depending on upcoming fundamental catalysts. The Jefferies Buy rating and USD 102.00 price target from October 3, 2023 still sit slightly above the recorded 52-week high of USD 101.60, underscoring that at least part of the analyst community projects the shares can revisit or surpass previous peaks if business performance and capital allocation stay on track.
Current price and trading data
Ventas Inc. stock is listed on the New York Stock Exchange under the ticker VTR, and the most recent completed session provides the reference price for the current assessment. Per NYSE data compiled by Yahoo Finance, the shares closed at USD 89.10 on September 14, 2026, after trading down 0.89 dollars from the prior close of USD 89.99, which corresponds to a decline of 0.99 percent for that day. The same quote summary shows that on that date the 52-week range extended from USD 66.54 to USD 101.60, framing the latest price action within a relatively wide corridor typical for a large diversified REIT with exposure to multiple healthcare segments.
Key data on Ventas Inc. stock
- Company: Ventas Inc.
- ISIN: US92276F1003
- Ticker: VTR
- Trading venue: NYSE
- Price (as of September 14, 2026): 89.10 USD
- Sector / Industry: Real Estate / Health Care REIT
- Index membership: S&P 500
